NS
AMEX · NSRX
Nasus Pharma Ltd.
Healthcare · Biotechnology
$3.62
Up+$0.42 (+13.12%)
Updated Aug 15, 2026, 5:57 AM
SID Score
4.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 58.89M
- P/E ratio
- -38.44
- Dividend yield
- 0.00%
- 52-week range
- $1.98 – $5.20
- Volume
- 27.45K
- Avg. volume
- 13.21K
Price performance
NSRX price history
1M range · 21 trading sessions · Daily adjusted prices
NSRX closed at $3.62 after 21 trading sessions, up 20.27% for the selected period.
- Last close
- $3.62
- Period change
- +20.27%
- Period low
- $2.91
- Period high
- $3.62
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 14, 2026 | $3.20 | $3.64 | $3.20 | $3.62 | 27.45K |
| Aug 13, 2026 | $3.08 | $3.49 | $3.05 | $3.20 | 6.84K |
| Aug 12, 2026 | $3.186 | $3.2384 | $3.13 | $3.2384 | 3.14K |
| Aug 11, 2026 | $3.40 | $3.40 | $3.2241 | $3.31 | 4.11K |
| Aug 10, 2026 | $3.26 | $3.51 | $3.21 | $3.35 | 15.39K |
| Aug 7, 2026 | $3.18 | $3.57 | $3.14 | $3.455 | 9.37K |
| Aug 6, 2026 | $3.22 | $3.4999 | $3.10 | $3.39 | 11.66K |
| Aug 5, 2026 | $3.47 | $3.57 | $3.15 | $3.32 | 19.89K |
| Aug 4, 2026 | $3.20 | $3.60 | $3.15 | $3.50 | 70.57K |
| Aug 3, 2026 | $3.04 | $3.19 | $2.97 | $3.19 | 8.25K |
| Jul 31, 2026 | $2.96 | $3.22 | $2.96 | $3.03 | 5.74K |
| Jul 30, 2026 | $3.02 | $3.19 | $3.02 | $3.18 | 2.44K |
| Jul 29, 2026 | $2.98 | $3.25 | $2.97 | $3.21 | 12.57K |
| Jul 28, 2026 | $2.96 | $3.15 | $2.96 | $3.03 | 16.56K |
| Jul 27, 2026 | $3.08 | $3.10 | $2.9601 | $3.09 | 12.34K |
| Jul 24, 2026 | $2.92 | $3.15 | $2.92 | $3.12 | 37.21K |
| Jul 23, 2026 | $2.90 | $3.093 | $2.8704 | $3.093 | 9.65K |
| Jul 22, 2026 | $2.90 | $3.06 | $2.90 | $2.91 | 6.09K |
| Jul 21, 2026 | $3.03 | $3.03 | $3.02 | $3.03 | 5.46K |
| Jul 20, 2026 | $2.96 | $3.02 | $2.96 | $3.01 | 4.58K |
| Jul 17, 2026 | $2.93 | $3.096 | $2.93 | $3.01 | 6.77K |
Latest NSRX news
The latest Smart Investors Daily articles mentioning NSRX.
Stock researchCompany · Dividend
Loading stock research…
